Advanced filters
News
Summit Therapeutics has announced it has completed dosing participants in its Phase II PhaseOut DMD…
News
Solid Biosciences has announced that the FDA has allowed the high-dose group to be included in the …
News
Pfizer has announced the first participant for its US-based gene therapy trial, was recently dosed…
News
New research has shown that certain mutations in a gene called SCN4A are associated with some cases…
News
AMO Pharma recently presented data from its trial investigating tideglusib (AMO-02) in teenagers…
News
Poor bone health is common in individuals with Duchenne muscular dystrophy. However, there is…
News
UPDATE (18/09/18): The researchers are still looking for volunteers for this study and have also…
News
We would like to invite you to take part in a study about anxiety in Duchenne muscular dystrophy.…
News
A recent preclinical study has identified a potential therapeutic target for Charcot Marie Tooth…
News
Dr Linda Popplewell and Professor George Dickson from Royal Holloway University took to Facebook…